Sustainable Chemistry and Pharmacy, 2022, 30:100881

Chemo-enzymatic synthesis of 5-substituted ribavirin analogs: Unexpected cooperative effect in the interaction of 5-alkyloxymethyl 1,2,4-triazol-3-carboxamides with E. coli purine nucleoside phosphorylase active site

A series of 5-alkyl/aryl-oxymethyl-ribavirin analogs was synthesized. Surprisingly, ability of E. coli purine nucleoside phosphorylase (PNP) to synthesize ribonucleosides and 2′-deoxyribonucleosides having structurally diverse alkyl(aryl)oxymethyl substituents at the 5 position of 1,2,4-triazol-3-carboxamide has been discovered. It has been shown that the enzymatic synthesis of 2′-deoxyribonucleosides proceeds with better conversion and is faster (up to 50 h) than the synthesis of ribonucleosides (more than 300 h). Therefore, ribonucleosides were synthesized by chemical glycosylation of base triazoles by 2,3,4,5-tetra-O-acetyl-D-ribose in the presence of bis(4-nitrophenyl) phosphate. 2′-Deoxyribonucleosides were synthesized by the transglycosylation reaction with E. coli PNP. For the first time, based on the kinetic parameters of the 2′-deoxyribonucleosides synthesis process, the positive cooperativity effect of wild type PNP active sites was discovered. The antiviral activity of nucleosides has been tested against herpes simplex virus type 1 (HSV-1) and influenza virus H5N1. The cytotoxicity and antiviral activity of the synthesized nucleosides differ, and it is impossible to draw an unambiguous conclusion about the structure-activity correlation.

Smirnova OS, Berzina MY, Fateev IV, Eletskaya BZ, Kostromina MA, Kayushin AL, Paramonov AS, Prutkov AN, Grebenkina LE, Chudinov MV, Andronova VL, Galegov GA, Deryabin PG, Miroshnikov AI, Esipov RS, Konstantinova ID

IBCH: 10344
Ссылка на статью в журнале: https://www.sciencedirect.com/science/article/pii/S2352554122002856?via%3Dihub
Кол-во цитирований на 04.2025: 3
Данные статьи проверены модераторами 2022-12-05

Список научных проектов, где отмечена публикация

  1. Моно- и полиферментные системы как основной инструмент в создании новых фармацевтически значимых модифицированных нуклеозидов и нуклеотидов (6 Января 2021 года — 31 Декабря 2023 года). Есипов Р.С.. Грант, РНФ.